NATIONAL VENTURE CAPITAL ASSOCIATION for NATIONAL VENTURE CAPITAL ASSOCIATION
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Energy/Nuclear ENG
Cleantech and Energy Policy issues. New Energy Innovation tax issues; Budget issues for FY2013 Energy and Taxes; ARPA-E Funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| MARK HEESEN | — |
| KELLY SLONE | — |
Banking BAN
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| MARK HEESEN | — |
| KELLY SLONE | — |
Immigration IMM
Support for S.310, Startup Act 3.0, S.169 Immigration Innovation Act of 2013; S.189, Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| MARK HEESEN | — |
| KELLY SLONE | — |
Science/Technology SCI
Basic science research funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| MARK HEESEN | — |
| KELLY SLONE | — |
Taxation/Internal Revenue Code TAX
Taxation of carried interest: capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means "partnership" tax reform discussion draft
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| MARK HEESEN | — |
| KELLY SLONE | — |
Telecommunications TEC
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and information sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act(CISPA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| MARK HEESEN | — |
| KELLY SLONE | — |
Health Issues HCR
No bill #. Lobbied Congress to work with the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway. That can be used for a broad set of discussions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| MARK HEESEN | — |
| KELLY SLONE | — |
Copyright/Patent/Trademark CPT
Shield Act of 2013, HR 845 - provide new limits to Patent Infringement lawsuits brought by non-practicing entitities. Monitored issues. Have not taken a position on the legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| MARK HEESEN | — |
| KELLY SLONE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.